Literature DB >> 22706294

Cervical human papillomavirus infection and shedding of human immunodeficiency virus in cervicovaginal fluids: a cross-sectional study.

Chiara Fornabaio1, Anna C C Carvalho, Flavia Lillo, José R Fiore, Viviana Bergamaschi, Sara Bigoni, Petra R Puzzi, Graziella Cristini, Mario Comelli, Maria R Parisi, Alberto Matteelli.   

Abstract

We evaluated the association between human papillomavirus cervical infection and HIV shedding in cervicovaginal lavage fluid (CVL), studying 89 HIV-infected women recruited at the Department of Infectious Diseases of Brescia (Italy). HIV shedding in CVL was found in a similar proportion of women with (30%; 21/70) and without (31.6%; 6/19) cervical human papillomavirus infection. A statistically significant correlation was found between HIV viral load in serum and CVL among the 27 women with detectable HIV in CVL (r = 0.4; P = 0.04). However, women on highly active antiretroviral therapy were more likely to have detectable HIV-RNA in CVL despite negative viremia (80% vs. 8%; P < 0.005).

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22706294     DOI: 10.1097/QAI.0b013e31826327a0

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  2 in total

1.  Immunologic, virologic, and pharmacologic characterization of the female upper genital tract in HIV-infected women.

Authors:  Lisa Rahangdale; Kristina De Paris; Angela D M Kashuba; Julie A E Nelson; Mackenzie Cottrell; Craig Sykes; Cindi Emerson; Steven L Young; Trenton Stevens; Kristine B Patterson; Myron S Cohen
Journal:  J Acquir Immune Defic Syndr       Date:  2015-04-01       Impact factor: 3.731

2.  Female genital tract shedding of HIV-1 is rare in women with suppressed HIV-1 in plasma.

Authors:  Julie A E Nelson; Kristina De Paris; Catalina Ramirez; Andrew Edmonds; Katie R Mollan; Camden P Bay; Kara Compliment; Betsy C Herold; Kathryn Anastos; Howard Minkoff; Seble Kassaye; Dominika L Seidman; Audrey L French; Elizabeth T Golub; Anandi N Sheth; Christina Ochsenbauer; Ronald Swanstrom; Joseph J Eron; Adaora A Adimora
Journal:  AIDS       Date:  2020-01-01       Impact factor: 4.632

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.